Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion

The aim was to determine whether losartan reduces cigarette smoke (CS)-induced airway inflammation and mucus hypersecretion in an in vitro model and a small clinical trial. Primary human bronchial epithelial cells (HBECs) were differentiated at the air–liquid interface (ALI) and exposed to CS. Expre...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:ERJ Open Res
Hoofdauteurs: Kim, Michael D., Baumlin, Nathalie, Dennis, John S., Yoshida, Makoto, Kis, Adrian, Aguiar, Carolina, Schmid, Andreas, Mendes, Eliana, Salathe, Matthias
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: European Respiratory Society 2021
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7836504/
https://ncbi.nlm.nih.gov/pubmed/33532463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00394-2020
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items